IOL CHEMICALS & PHARM. has announced its results for the year ended March 2021. Let us have a look at the detailed performance review of the company during FY20-21.
No. of Mths Year Ending | 12 Mar-20* | 12 Mar-21* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 18,945 | 19,670 | 3.8% |
Other income | Rs m | 160 | 243 | 51.7% |
Total Revenues | Rs m | 19,105 | 19,913 | 4.2% |
Gross profit | Rs m | 5,739 | 5,918 | 3.1% |
Depreciation | Rs m | 357 | 389 | 8.9% |
Interest | Rs m | 209 | 58 | -72.1% |
Profit before tax | Rs m | 5,332 | 5,714 | 7.2% |
Tax | Rs m | 1,720 | 1,268 | -26.2% |
Profit after tax | Rs m | 3,613 | 4,446 | 23.0% |
Gross profit margin | % | 30.3 | 30.1 | |
Effective tax rate | % | 32.2 | 22.2 | |
Net profit margin | % | 19.1 | 22.6 |
Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
No. of Mths Year Ending | 12 Mar-20* | 12 Mar-21* | % Change | |
---|---|---|---|---|
Networth | Rs m | 8,042 | 12,604 | 56.7 |
Current Liabilities | Rs m | 4,536 | 4,328 | -4.6 |
Long-term Debt | Rs m | 0 | 0 | 0.0 |
Total Liabilities | Rs m | 13,469 | 17,523 | 30.1 |
Current assets | Rs m | 8,479 | 11,645 | 37.3 |
Fixed Assets | Rs m | 4,990 | 5,878 | 17.8 |
Total Assets | Rs m | 13,469 | 17,523 | 30.1 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-20 | Mar-21 | ||
Cash Flow from Operating Activities | Rs m | 4,708 | 3,798 | -19.3% |
Cash Flow from Investing Activities | Rs m | -1,842 | -3,173 | - |
Cash Flow from Financing Activities | Rs m | -2,719 | -583 | - |
Net Cash Flow | Rs m | 147 | 43 | -71.0% |
No. of Mths Year Ending | 12 Mar-20* | 12 Mar-21* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 333.0 | 335.0 |
TTM Earnings per share | Rs | 63.5 | 75.7 |
Diluted earnings per share | Rs | 61.5 | 75.7 |
Price to Cash Flow | x | 2.6 | 6.5 |
TTM P/E ratio | x | 2.9 | 7.3 |
Price / Book Value ratio | x | 1.6 | 2.5 |
Market Cap | Rs m | 13,202 | 31,493 |
Dividends per share (Unadj.) | Rs | 3.0 | 6.0 |
Current Ratio: The company's current ratio improved and stood at 2.7x during FY21, from 1.9x during FY20. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 99.0x during FY21, from 26.5x during FY20. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company declined and down at 35.3% during FY21, from 44.9% during FY21. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company declined and down at 45.8% during FY21, from 68.9% during FY20. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company declined and down at 25.7% during FY21, from 28.4% during FY20. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-20* | 12 Mar-21* | |
---|---|---|---|
Current ratio | x | 1.9 | 2.7 |
Debtors’ Days | Days | 5 | 6 |
Interest coverage | x | 26.5 | 99.0 |
Debt to equity ratio | x | 0.0 | 0.0 |
Return on assets | % | 28.4 | 25.7 |
Return on equity | % | 44.9 | 35.3 |
Return on capital employed | % | 68.9 | 45.8 |
To see how IOL CHEMICALS & PHARM. has performed over the last 5 years, please visit here.
Over the last one year, IOL CHEMICALS & PHARM. share price has moved up from Rs 176.2 to Rs 550.6, registering a gain of Rs 374.5 or around 212.6%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,328.2 (up 0.4%). Over the last one year it has moved up from 12,148.6 to 21,328.2, a gain of 9,180 points (up 75.6%).
Overall, the S&P BSE SENSEX is up 74.1% over the year.
(To know more, check out historical annual results for IOL CHEMICALS & PHARM. and quarterly results for IOL CHEMICALS & PHARM.)
IOL CHEMICALS & PHARM. currently trades at Rs 399.5 per share. You can check out the latest share price performance of IOL CHEMICALS & PHARM. here...
The revenues of IOL CHEMICALS & PHARM. stood at Rs 19,913 m in FY21, which was up 4.2% compared to Rs 19,105 m reported in FY20.
IOL CHEMICALS & PHARM.'s revenue has grown from Rs 6,494 m in FY17 to Rs 19,913 m in FY21.
Over the past 5 years, the revenue of IOL CHEMICALS & PHARM. has grown at a CAGR of 32.3%.
The net profit of IOL CHEMICALS & PHARM. stood at Rs 4,446 m in FY21, which was up 23.0% compared to Rs 3,613 m reported in FY20.
This compares to a net profit of Rs 2,367 m in FY19 and a net profit of Rs 277 m in FY18.
Over the past 5 years, IOL CHEMICALS & PHARM. net profit has grown at a CAGR of 212.4%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of IOL CHEMICALS & PHARM. reveals:
Here's the cash flow statement of IOL CHEMICALS & PHARM. for the past 5 years.
(Rs m) | FY17 | FY18 | FY19 | FY20 | FY21 |
---|---|---|---|---|---|
From Operations | 833 | 1,197 | 2,732 | 4,708 | 3,798 |
From Investments | -228 | -504 | -630 | -1,842 | -3,173 |
From Financial Activity | -598 | -704 | -1,975 | -2,719 | -583 |
Net Cashflow | 8 | -10 | 127 | 147 | 43 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of IOL CHEMICALS & PHARM. reveals:
Here's the ratio/financial analysis of IOL CHEMICALS & PHARM. for the past 5 years.
FY17 | FY18 | FY19 | FY20 | FY21 | |
---|---|---|---|---|---|
Operating Profit Margin (%) | 15.8 | 12.4 | 24.3 | 30.3 | 30.1 |
Net Profit Margin (%) | 0.7 | 2.9 | 14.0 | 19.1 | 22.6 |
Debt to Equity Ratio (x) | 1.5 | 1.2 | 0.4 | 0.0 | 0.0 |
Read: Latest Annual Report Analysis of IOL CHEMICALS & PHARM.
Equitymaster requests your view! Post a comment on "IOL CHEMICALS & PHARM. 2020-21 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!